Professor Richard Darley



Prosiectau fel Prif Ymchwiliwr
null null 1 o 2 null null

Targets for treatment in AML: discovery and translation - Cyllidwr:Blood Cancer UK (20.09.2015 - 23.08.2019)
The role of reactive oxygen species in acute myeloid leukaemia - Cyllidwr:Kay Kendall Leukaemia Fund (01.11.2010 - 31.12.2012)
Targets for treatment in AML: Discovery and translation - Cyllidwr:Blood Cancer UK (01.04.2010 - 19.09.2013)
Mechanisms dysregulating canonical Wnt signalling in acute myeloid leukaemia - Cyllidwr:Cancer Research Wales (01.10.2013 - 31.12.2016)
Targets for treatment in AML: Discovery and translation - Cyllidwr:Blood Cancer UK (20.09.2013 - 01.12.2015)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 3 null null

Development of novel CD200:CD200R blockade cancer immunotherapy - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.06.2015 - 31.05.2016)
Cardiff Experimental Cancer Medicine Centre - Cyllidwr:Cancer Research UK, - Cyllidwr:Welsh Government (HCRW) (01.04.2012 - 31.03.2017)
Targeting CD200 signalling to overcome cell carcinoma immune evasion - Cyllidwr:British Skin Foundation (01.01.2014 - 31.07.2017)

Diweddarwyd y tro diwethaf ar 2021-01-03 am 22:00